Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Yuxing Bio-Engineering Co., Ltd., often referred to as Yuxing Biotechnology Group, is a leading global manufacturer of Vitamin B12 and its derivatives. Established in 1987 and headquartered in Ningjin, China, the company operates one of the world's largest production bases for Cyanocobalamin, Methylcobalamin, and Adenosylcobalamin. Yuxing specializes in large-scale fermentation and high-purity chemical synthesis, providing active pharmaceutical ingredients (APIs) to the pharmaceutical, nutraceutical, and animal feed industries. The company's facilities are GMP-certified and its products meet international pharmacopoeia standards such as USP, EP, and BP. As a dominant player in the Vitamin B12 market, Yuxing supplies a significant portion of the global demand for these essential nutrients. The company continues to invest in industrial biotechnology to optimize production efficiency and maintain its competitive position in the global API market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yuxing Biotechnology Group.